MyFinsight
Home
Blog
About
Contact
Download
Download image
DE
$24,504K
(30.91%↑ Y/Y)
FR
$22,878K
(28.10%↑ Y/Y)
Other International
Markets
$15,679K
(31.35%↑ Y/Y)
JP
$10,243K
(17.61%↑ Y/Y)
Net income (loss)
-$71,138K
(-107.28%↓ Y/Y)
US
$95,956K
(3.01%↑ Y/Y)
International Markets
$73,304K
(28.10%↑ Y/Y)
CN
$4,795K
(3.86%↑ Y/Y)
Income (loss) before
income tax
-$69,258K
(-128.61%↓ Y/Y)
Income tax
$1,880K
(-53.28%↓ Y/Y)
Net revenues
$174,055K
(12.30%↑ Y/Y)
Operating income (loss)
-$67,420K
(-78.05%↓ Y/Y)
Financial income
(expenses), net
-$1,838K
(-124.28%↓ Y/Y)
Gross profit
$135,126K
(16.01%↑ Y/Y)
Cost of revenues
$38,929K
(1.06%↑ Y/Y)
Total operating costs
and expenses
$202,546K
(31.24%↑ Y/Y)
General and
administrative
$85,853K
(91.77%↑ Y/Y)
Sales and marketing
$58,357K
(4.60%↑ Y/Y)
Research, development and
clinical studies
$58,336K
(8.48%↑ Y/Y)
Back
Back
Income Statement
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)
source: myfinsight.com